Iran unveils second homegrown COVID-19 vaccine

A handout image provided by Iran’s State Television shows Tayebeh Mokhber (R), daughter of the head of Execution of Imam Khomeini’s Order, waiting to get injected with the Coviran homegrown COVID-19 vaccine during the first Iranian Covid-19 vaccine trial, Phase I in Tehran, Iran, on December 29, 2020 [Iran’s State Television – Anadolu Agency]

Iran on Sunday unveiled its second homegrown COVID-19 vaccine, based on a recombinant protein that can be injected or inhaled, Anadolu Agency reported.

The COV-Pars vaccine, developed by the country’s oldest scientific research centre, Razi Vaccine and Serum Research Institute, is expected to undergo human trials from Monday.

Speaking at the unveiling ceremony in Tehran, Iran’s Health Minister Saeed Namaki expressed hope that the country will emerge as a “hub of vaccine production” in coming months.

It is the second homegrown vaccine that has reached human trials phase, after CovIran, which is developed by Baraket Pharmaceutical Group allied with a government organisation.

The vaccines have been developed under the supervision of Iran’s Health Ministry and in compliance with standards set by the World Health Organisation (WHO), officials said.

Read: Iran imposes mandatory quarantine for travellers from Europe

Namaki said the homegrown vaccine was a combination of inhaled dose and injection that can stimulate the immune system, adding that the vaccine has very “few side effects” that can be “reconfigured” in case of virus mutations.

Namaki said they followed through three steps, including reliance on domestic knowledge-based companies, procuring technical knowhow from other countries and importing vaccines from reliable sources like Russia.

On Russia-made vaccine Sputnik V vaccine, which Iran imported this week and which will be used in the first phase of vaccination program, Namaki said Iran was among the first countries to negotiate with Russia on it and decided to import the vaccine after it had passed different phases of testing.

Iran, the worst-affected country in the region from the virus, will begin vaccination rollout this week with high-risk groups like healthcare workers, elderly and ailing.

Albeit the situation has improved in recent months, the rise in new infections in recent days has raised fears of a fourth wave of the virus, a concern expressed by senior health officials.

Iran has so far reported 1.46 million cases of the virus since its outbreak in February last year with 58,000 fatalities.

Unless otherwise stated in the article above, this work by Middle East Monitor is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. If the image(s) bear our credit, this license also applies to them. What does that mean? For other permissions, please contact us.